microRNAs in inflammatory alveolar bone defect: A review

Area of Science:

• Oral biology
• Molecular biology
• Biomedical science

Background:

• Inflammatory alveolar bone defects are common oral diseases caused by periodontal pathogens, leading to periodontal support tissue damage.
• MicroRNAs (miRNAs) are key regulators of gene expression, influencing inflammatory processes and bone metabolism.
• Emerging evidence highlights the significant role of specific miRNAs in the pathogenesis of inflammatory alveolar bone defects.

Purpose of the Study:

• To review the current literature on the correlation between microRNAs and inflammatory alveolar bone defects.
• To elucidate the underlying molecular mechanisms by which miRNAs influence the development of these defects.
• To identify potential miRNA-based therapeutic targets for prevention and treatment.

Main Methods:

• Comprehensive literature search of studies investigating miRNAs in inflammatory alveolar bone defects.
• Analysis of miRNA biogenesis, function, and target gene regulation in the context of bone metabolism.
• Review of experimental evidence linking specific miRNAs to periodontal disease progression and bone loss.

Main Results:

• Several miRNAs have been identified as critical players in the inflammatory pathways and bone remodeling associated with alveolar bone defects.
• miRNAs regulate key genes involved in osteoblast differentiation, osteoclastogenesis, and inflammatory responses.
• Dysregulation of specific miRNAs contributes to the severity and progression of inflammatory alveolar bone defects.

Conclusions:

• MicroRNAs represent a significant regulatory layer in the pathogenesis of inflammatory alveolar bone defects.
• Targeting specific miRNAs holds promise for developing novel diagnostic and therapeutic interventions for periodontal diseases.
• Further research into miRNA-mediated mechanisms can pave the way for innovative treatments to preserve periodontal support tissues.